Clinical Trial Update: DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS) [Phase 3]

View source ↗

Summary

The DARWIN Phase 3 trial of Dexloxiglumide for constipation-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Dexloxiglumide (Dexloxiglumide)

Snippet

Sponsor: Rottapharm | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED